Seegene, Stock Price Down 18.6% at This Hour... 278,919 Shares Net Bought by Individuals in Last 5 Days
As of 2:31 PM on the 14th, Seegene is trading at 222,800 KRW, down 18.6% from the previous day. The trading volume is 4,291,064 shares, which is 231.84% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.
On August 14th, KTB Investment & Securities researcher Kang Ha-young stated, "1) From August, the global number of COVID-19 confirmed cases appears to have stabilized, and considering reagent export data and supply competition, there is a high possibility that 2Q quarterly earnings have peaked. 2) The stock price, which has surged nearly 800% year-to-date, may lead to deteriorating investor sentiment if COVID-19 vaccine and treatment development results are confirmed, so caution is needed." He set Seegene's target price at 230,000 KRW.
Over the past five days, individual investors have net purchased 278,919 shares of Seegene, while foreigners and institutions have net sold 168,201 shares and 112,221 shares, respectively.

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Trump Puts Iran Strike on Hold One Day Before Attack... "Full-Scale Offensive If Talks Fail"
- [New York Stock Market] Mixed Close Amid Tech Stock Declines and Stalled Ceasefire Talks
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.